This trial is studying whether virtual reality technology can help reduce pain for people with sickle cell disease who are experiencing an acute pain crisis.
1 Primary · 0 Secondary · Reporting Duration: Baseline and up to 30 minutes after intervention
Active Control
76 Total Participants · 2 Treatment Groups
Primary Treatment: Virtual Reality · No Placebo Group · N/A
Age 6 - 25 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: